http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1133459-B1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_10e4b1416c6e66e0ade5429212414964
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C211-42
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C211-42
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-90
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C209-84
filingDate 1999-11-24-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2006-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4e54e974d72bb6339dfa25e248003407
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d88c092460b1b83654590c5b1a209a31
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eff86049181af6760150bd296ef7781b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_51e432ef09eadbe79803eb00de15660d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f4bb8a4a0e540a32d28f8f8c002b3c48
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0735408ed4e54eb5833e944c7ab31af4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4b81592f11595bf32e699c7be3a6411a
publicationDate 2006-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1133459-B1
titleOfInvention Sertraline hydrochloride form v
abstract The present invention is directed to forms II, III, V, VI, VII, VIII, IX and X of sertraline hydrochloride and novel methods for their preparation. According to the present invention, sertraline hydrochloride polymorph II may be produced by slurrying sertraline hydrochloride polymorph VI in aprotic organic solvent. Sertraline hydrochloride polymorphic form III may be produced by heating sertraline hydrochloride polymorphs V and VI. Sertraline hydrochloride forms V and VI may be produced from either sertraline hydrochloride or sertraline base by crystallization. Sertraline hydrochloride Form VII may be produced by suspending sertraline chloride polymorph V in water, followed by filtration. Sertraline hydrochloride Forms VIII and IX may be produced by suspending sertraline base in water followed by acidification and filtration. Sertraline hydrochloride Form X and be produced by suspending sertraline hydrochloride in benzyl alcohol with heating, followed by filtration.
priorityDate 1998-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7900
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID63009
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226415961
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226393293
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226405837
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227439297
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226412016
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129471329
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7909
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID68617
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID244
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID53859258
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10479278
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID227439711
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127450492

Total number of triples: 41.